RecruitingPhase 3NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Sponsor: GlaxoSmithKline
Aurora, CO · +56 more sites
7 recruiting copd studies with a site in Aurora, CO.
Sponsor: GlaxoSmithKline
Aurora, CO · +56 more sites
Sponsor: AstraZeneca
Aurora, CO · Denver, CO · Englewood, CO · +232 more sites
Sponsor: Expedition Therapeutics, Inc
Aurora, CO · +21 more sites
Sponsor: VA Office of Research and Development
Aurora, CO · +4 more sites
Sponsor: University of Colorado, Denver
Aurora, CO
Sponsor: University of Colorado, Denver
Aurora, CO
Sponsor: University of Colorado, Denver
Aurora, CO
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.